Laura Carter is CSO at Gossamer Bio, Inc. (GOSS). They have made 7 open-market trades across 1 company since 2021, most recently 2023-03-16.
CIK 0001858178
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $50K since 2022, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GOSS | 76,263 | $663K |
Shares reported on the most recent Form 4, priced at the 2023-03-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GOSS | SELL | 2023-03-16 | 2023-03-20 | $1.10 | $7K | +2.5% | -15.1% | +10.5% |
| GOSS | SELL | 2022-10-24 | 2022-10-27 | $12.07 | $118K | -6.6% | -19.7% | -78.9% |
| GOSS | BUY | 2022-07-15 | 2022-07-15 | $7.21 | $50K | +3.0% | +23.2% | +5.3% |
| GOSS | SELL | 2022-07-01 | 2022-07-05 | $8.25 | $73K | +27.6% | +48.0% | +34.3% |
| GOSS | SELL | 2022-05-04 | 2022-05-05 | $7.20 | $9K | +21.0% | -5.7% | +71.6% |
| GOSS | SELL | 2022-03-16 | 2022-03-17 | $8.28 | $41K | +1.0% | -2.4% | -31.6% |
| GOSS | SELL | 2021-10-25 | 2021-10-26 | $12.25 | $29K | +5.6% | -15.4% | -17.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.